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Evaluation and Management of Acute Kidney Injury Emergencies 
Megan Musisca, MD 
 
Acute kidney injury (AKI) presents unique challenges for physicians caring for patients in the 
Emergency department.  The presentation and severity of AKI is variable.  AKI, with severe life-threatening 
laboratory abnormalities, may present with multi-organ failure or with vague/minimal clinical findings.  
Therefore, physicians must have a high index of suspicion for AKI.    
 
DEFINITION OF AKI: 
AKI can be defined as a rapid decrease in glomerular filtration rate (GFR) over hours to weeks in the 
setting of previously normal renal function or preexisting renal disease.  Acute renal failure (ARF) represents a 
subset of patients with AKI who require renal replacement therapy or dialysis and are more often critically ill.1 
Several criteria exist to define and help diagnose AKI.  One of the more commonly used is the RIFLE 
criteria, developed by the Acute Dialysis Quality Initiative which defines AKI severity based on serum Cr, GFR, 
and urine output (see table 1).1  Serum creatinine levels lag renal injury and recovery, therefore creatinine has 
poor sensitivity and specificity for AKI by itself.2  The pRIFLE criteria include modifications for pediatric patients 
based on estimated creatinine clearance (eCCl) as calculated by the Schwartz formula.3-4  The KDIGO stages 
of AKI are also applicable to the pediatric population (table 2).5 
Table 1: RIFLE and pRIFLE Criteria for Acute Kidney Injury 
 RIFLE Criteria pRIFLE (Pediatric) Criteria 
R – Risk of renal injury 1.5x increase of baseline serum Cr (sCr) 
(50% increase) 
OR 
decrease in GFR >25% from baseline  
OR 
urine output of <0.5 ml/kg/hr for ≥6 hr 
Estimated Cr Clearance (eCCl) decrease 
of 25% 
OR 
urine output of <0.5 ml/kg/hr for ≥8 hr 
I – Renal injury 2x increase of baseline sCr  
OR 
urinary output <0.5 ml/kg/hr for ≥12 hr 
eCCl decrease of 50% 
OR 
urine output of <0.5 ml/kg/hr for ≥16 hr 
F – Renal failure 3x increase of baseline sCr  
OR 
sCr > 4mg/dl with an acute rise of 0.5 
mg/dl 
eCCl decrease of 50% 
OR 
urine output of <0.3 ml/kg/hr for ≥24 hr or 




decrease in GFR of >75% from baseline 
OR 
urine output <0.3 ml/kg/hr for ≥24 hr or 
anuria for ≥12 hr 
L – Loss of Renal 
function 
Renal failure with need for RRT (>4 wk) 
E – End stage renal 
disease 
Non-recovery of renal function (RRT > 3 mo) 
 
Table 2: AKI Staging per the KDIGO Clinical Practice Guideline 
 Serum Criteria Urine Criteria 
Stage 1 Increase in serum creatinine (sCr) 
by >0.3 mg/dL  
 
1.5-1.9 times baseline. 
Output <0.5 ml/kg/hr for 6-12 hours 
Stage 2 Increase in sCr by 2-2.9 times 
baseline 
Output <0.5 ml/kg/hr for >12 hours 
Stage 3 In pediatric patients: a decrease in 
eGFR to 35 ml/min/1.73 m2 
 
sCr >4 mg/dL 
 
Started on renal replacement 
therapy 
 
Increase in sCr by 3 times baseline 
 
Output <0.3 ml/kg/hr for >24 hours 
 
Anuria for >12 hours 
 
ETIOLOGIES OF AKI: 
The etiologies of AKI can be separated into three general categories: pre-renal, intrinsic renal, and 
post-renal causes.  Pre-renal kidney injury is often due to a relative hypovolemic state or decreased kidney 
perfusion.  This can occur in patients with dehydration, gastrointestinal losses, severe blood loss, distributive or 
hypovolemic shock, or some medications (i.e. NSAIDS, ACE-inhibitors).  If caught early, this is often reversible 
with volume resuscitation or discontinuation of the offending agent.  Intrinsic renal injury is due to glomerular or 
tubular injury and is not always reversible.  This can occur in the setting of a prolonged pre-renal state, 
nephrotoxic medications, systemic disease, or primary kidney disease.  Post-renal injury occurs with urinary 
obstruction either from bilateral ureteral obstruction from kidney stones or mass, severe unilateral kidney 
obstruction, bladder outlet obstruction, or neurogenic bladder.6   
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The etiology of kidney injury can be determined with a thorough history and physical examination along 
with supportive laboratory studies.  Calculating the fractional excretion of sodium (FeNa) may be useful in 
patients with previously normal kidney function.  A value less than 1% may indicate pre-renal etiology while 
values >2% supports intrinsic renal injury.  If the patient has chronic kidney disease or prior diuretic use, 
calculating the fractional excretion of urea (FeUrea) is more helpful.  A value <35% is indicative of pre-renal 
etiology. 
 
MANAGEMENT OF AKI EMERGENCIES 
As with any emergency medical condition, initial assessment begins with airway, breathing, and 
circulation (A, B, C’s).  Vital signs should be obtained, including blood pressure.  Ill-appearing patients should 
be placed on continuous monitoring and IV access obtained.  If AKI is suspected, evaluation should be focused 
on life threatening complications of AKI or renal failure (table 3).  Preliminary laboratory studies that might be 
helpful include complete blood counts, electrolytes, BUN, Cr, urinalysis, and further urine studies (typically Na, 
urea, protein, and creatinine). 
Table 3: Life threatening complications of acute kidney injury  
Life threatening complications of AKI 









 Hypervolemia is a severe complication of oliguric/anuric AKI.  It can manifest with peripheral or facial 
edema, pulmonary edema, respiratory distress/failure, and heart failure.  Fluid overload may be managed with 
diuretic medications, fluid restriction, or renal replacement therapy (RRT) in severe cases.  Diuretics may 
improve fluid overload and reduce use of RRT, but has not shown to improve AKI outcomes.4  Immediate 
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initiation of dialysis should be considered in consultation with a nephrologist if fluid overload is refractory to 
medications or the patient has anuria.  
Patients with AKI due to pre-renal causes can be hypovolemic and fluid resuscitation may improve the 
kidney injury.   Intravenous (IV) crystalloid or colloid fluids may be used, but adult studies have shown that 
there is no benefit of albumin or starch containing fluids over saline and some starch containing IV fluids may 
worsen AKI.5,7  For these reasons, it is recommended to use normal saline (NS) fluids5 keeping in mind that 
aggressive fluid administration may cause acute fluid overload in a patient with AKI or heart disease.  One 
must monitor urine output and watch for symptoms of pulmonary edema or heart failure, especially if 
prescribing multiple boluses.  One caveat regarding the preference for NS fluids is that some patients may 
benefit from 25% albumin infusion followed with IV diuretics, particularly if they have had significant saline 
volume resuscitation and have nephrotic syndrome with hypoalbuminemia.  Vasopressors should be used if 
the patient is persistently hypovolemic despite adequate resuscitation. 
 
URINARY OBSTRUCTION 
Urinary obstruction causes post-renal AKI and is a condition that should be recognized and treated 
quickly.  Obstructive AKI should be suspected in patients with voiding difficulties, bladder outlet obstruction, 
oliguria or anuria.  Placement of a urinary catheter can relieve obstruction, improve AKI, and help quantify 
urine output.  Physical exam may reveal a suprapubic or abdominal mass and bedside ultrasound may confirm 
a distended bladder.  It is important to remember that obstructive uropathy leading to AKI can also occur above 
the level of the urethra and catheterization may not improve the obstruction.  Further imaging such as 
ultrasound and consultation with nephrology or urology should be considered. 
 
HYPERTENSION 
Acute or severe hypertension can be life-threatening as it can cause end organ damage, particularly in 
the heart, brain, and kidney.  The etiology of hypertension in acute kidney injury patients may be due to fluid 
overload or elevated activity of the renin-angiotensin pathway causing systemic vasoconstriction.  
Hypertensive urgency is generally defined as SBP >= 180 mmHg and/or DBP >= 110 or greater than 5 mmHg 
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above the 99th%tile for age in pediatric patients.  Hypertensive emergency is defined as hypertensive urgency 
with associated clinical symptoms of end-organ dysfunction such as headache, confusion, vision changes, 
weakness, chest pain, shortness of breath, etc.  
In hypertensive urgency and emergency, blood pressure should be lowered carefully over minutes to 
hours.  The treatment goal is to reduce severity of hypertension and alleviate signs of end organ dysfunction, 
not to completely normalize blood pressure.  Medications commonly used in the acute care or emergency 
setting include labetolol, nicardipine, hydralazine, esmolol, or nifedipine.8 ACE inhibitors may exacerbate a pre-




Hyperkalemia or elevated serum potassium level is a life-threatening electrolyte abnormality that can 
progress to fatal cardiac arrhythmia. Symptomatic hyperkalemia may not be present unless levels are ≥ 7 
mEq/L.  Indications for immediate treatment of hyperkalemia include EKG findings of narrow, peaked T-waves, 
shortened QT interval followed by widened QRS, lengthening of PR interval, and low amplitude P waves.6 
Strategies for treating hyperkalemia begin by stabilizing the cardiac cellular membranes with IV calcium 
therapy then reducing circulating potassium levels by shifting potassium into cells and thereafter decreasing 
total body potassium.  IV calcium gluconate or calcium chloride may be used for calcium therapy, but both 
cause tissue necrosis and central access is preferred. 
Shifting potassium into cells with medications that stimulate the Na-K-ATPase pump in skeletal muscle 
reduces circulating levels of K+, but does not reduce the total body potassium.  A temporary shift can be 
accomplished with albuterol inhalation, IV insulin (always given with glucose to avoid complications of 
hypoglycemia), or IV bicarbonate. 
Removing total body potassium can be accomplished by two main modalities: urinary or fecal excretion.  
Loop diuretic therapy causes renal excretion of K+, but this is not useful in patients with non-functional kidneys, 
dialysis patients, or anuric paitents. Fecal excretion is often achieved with oral or rectal potassium binding 
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resins such as sodium polystyrene sulfonate- Kaexylate®.  This is a slower route for removal and may require 
repeat dosing.  
If hyperkalemia is refractory to medical management, dialysis should be considered in consultation with 
a nephrologist.  
 
ACIDOSIS  
The retention of hydrogen ions or loss of bicarbonate through renal wasting in AKI can lead to acidosis. 
Acidosis may also be present in AKI due to an underlying cause such as sepsis, shock, or toxic ingestion.  
Severe acidosis is a metabolic derangement that can lead to cardiopulmonary compromise if untreated.  It is 
recommended to correct acidosis by treating the underlying cause and with intravenous bicarbonate if 
necessary.  Rarely, emergent dialysis is necessary to correct acidosis alone.5 
 
UREMIA 
Since the kidney filters urea, elevated serum urea levels (elevated serum BUN level) can occur in the 
setting of AKI.  Azotemia is defined as elevated serum BUN.  Uremia is the clinical manifestation of azotemia in 
the setting of acute renal failure.  Notable features of uremia are encephalopathy, nausea/vomiting, metabolic 
acidosis, and uremic platelet dysfunction.  If untreated, it leads to severe encephalopathy, coma, and death.  
Uremia may improve with correction of kidney injury, but the presence of uremia is an indication for emergent 
dialysis.  
 
DIALYSIS IN THE EMERGENCY DEPARTMENT 
Practices vary by institution depending on access to nephrology specialists and dialysis related 
resources.  Life-threatening indications for dialysis include severe hyperkalemia, severe acidosis, uremia, and 
pulmonary edema, but the decision to begin RRT remains subjective and consultation with a nephrologist is 
recommended.5 
Generally, the emergent modes of dialysis include intermittent hemodialysis or continuous renal 
replacement therapy (CRRT).  CRRT can employ clearance and volume control by diffusion (continuous veno-
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venous hemodialysis; CVVHD) or by convection (continuous veno-venous hemofiltration; CVVH) or both 
diffusion and convection simultaneously (continuous veno-venous hemodiafiltration; CVVHDF).  Peritoneal 
dialysis requires surgical peritoneal catheter placement and provides slow solute and fluid removal over hours, 
making this modality more appropriate for end stage renal disease management although it can be used for 
AKI.  Intermittent hemodialysis has advantages over CRRT with shorter cycle time and more rapid removal of 
solute and fluid.  However, hemodynamically unstable patients may not tolerate the higher flow rates typically 
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